![](/img/cover-not-exists.png)
First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation
Zhao, Xiang-Yu, Pei, Xu-Ying, Chang, Ying-Jun, Yu, Xing-Xing, Xu, Lan-Ping, Wang, Yu, Zhang, Xiao-Hui, Liu, Kai-Yan, Huang, Xiao-JunLanguage:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciz368
Date:
May, 2019
File:
PDF, 2.25 MB
english, 2019